« Back to Record
Citation APA

Angevin, E., Tabernero, J., Elez, E., Cohen, S., Bahleda, R., Van Laethem, J.-L., Ottensmeier, C., Lopez-Martin, J. J., Clive, S., Joly, F., Ray-Coquard, I., Dirix, L. Y., Machiels, J.-P., Steven, N., Reddy, M., Hall, B., Puchalski, T. T., Bandekar, R., Van De Velde, H., Tromp, B., Vermeulen, J., & Kurzrock, R. (2014). A Phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors. Clinical cancer research, 20(8), 2192-2204. doi:10.1158/1078-0432.CCR-13-2200


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168757

Angevin, E., Tabernero, J., Elez, E., Cohen, S., Bahleda, R., Van Laethem, J.-L., Ottensmeier, C., Lopez-Martin, J. J., Clive, S., Joly, F., Ray-Coquard, I., Dirix, L. Y., Machiels, J.-P., Steven, N., Reddy, M., Hall, B., Puchalski, T. T., Bandekar, R., Van De Velde, H., Tromp, B., Vermeulen, J., & Kurzrock, R. (2014). A Phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors. Clinical cancer research, 20(8), 2192-2204. doi:10.1158/1078-0432.CCR-13-2200